Shaanxi Meibang Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd capital reinvestment ratio. Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥281.88 Million) in capital expenditures (CN¥54.40 Million). Check how aggressively does Shaanxi Meibang Pharmaceutical Group Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Capital reinvestment ratio of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. This chart tracks Shaanxi Meibang Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 7 annual periods. Also explore 605033 net assets growth trend to track the company's year-over-year net asset growth rate.
Shaanxi Meibang Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2017–2024)
Shaanxi Meibang Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see 605033 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | CN¥280.40 Million | CN¥158.81 Million | ▼ -6.9% |
| 2023 | 0.61x | CN¥334.79 Million | CN¥203.69 Million | ▼ -29.6% |
| 2022 | 0.86x | CN¥126.41 Million | CN¥109.29 Million | ▲ +4.9% |
| 2020 | 0.82x | CN¥74.88 Million | CN¥61.71 Million | ▲ +213.4% |
| 2019 | 0.26x | CN¥128.45 Million | CN¥33.78 Million | ▼ -87.2% |
| 2018 | 2.06x | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥29.41 Million | CN¥17.56 Million | — |